Product image of Mycoster (Ciclopirox Olamine) supplied by GNH India

Mycoster

Active Ingredient:
Ciclopirox Olamine
Origin:
EU

Mycoster (Ciclopirox Olamine)

Ciclopirox Olamine, the active ingredient in Mycoster, is an antifungal (hydroxypyridone) presented as a topical formulation for skin use. It treats fungal skin infections such as dermatophyte, candidal and seborrheic conditions in both adults and children.

GNH India supplies Mycoster as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pierre Fabre Medicament

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mycoster, a topical antifungal, is employed to manage fungal skin conditions across several disease categories.

  • Dermatophyte infections: reduces fungal growth and promotes resolution of skin lesions.
  • Candidal skin infections: alleviates itching, redness and clears the infection.
  • Seborrheic dermatitis: controls Malassezia overgrowth and improves scaling and erythema.

How It Works

  • Ciclopirox Olamine chelates polyvalent cations such as Fe³⁺ and Al³⁺, inhibiting metal‑dependent enzymes essential for fungal cell membrane transport and metabolic processes. This disruption impairs fungal cell respiration and synthesis of essential proteins, leading to inhibition of growth and eventual cell death without affecting human cells.

Side Effects

Adverse reactions are generally limited to the application site, though systemic effects are rare.

Common Side Effects

  • Local irritation: mild burning or stinging sensation.
  • Itching: transient pruritus at the site of application.
  • Redness: erythema surrounding the treated area.
  • Dryness: skin may become dry or flaky.
  • Scaling: mild flaking of the outer skin layer.
  • Contact dermatitis: mild allergic response.

Serious or Rare Side Effects

  • Allergic contact dermatitis: severe rash with swelling.
  • Urticaria: hives developing after application.
  • Angioedema: swelling of deeper skin layers, potentially affecting the face.
  • Systemic absorption reactions: rare hepatic enzyme alterations.
  • Severe skin necrosis: extremely uncommon but requires immediate medical attention.
  • Anaphylaxis: rare systemic allergic reaction.

Precautions & Warnings

When using Mycoster, consider the following safety measures.

  • Avoid use on broken or inflamed skin: may increase irritation.
  • Do not apply to eyes, mucous membranes or genital area: product is for external use only.
  • Use only as directed by a healthcare professional: follow prescribed frequency and duration.
  • Discontinue if severe irritation or allergic reaction occurs: seek medical advice.
  • Keep out of reach of children: store securely.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Topical ciclopirox has limited systemic interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid)

  • Concurrent use with other topical antifungals: may increase local irritation.
  • Application together with potent corticosteroids: can reduce antifungal effectiveness.
  • Use under occlusive dressings: may enhance absorption and cause irritation.

Moderate Interactions (Monitor Closely)

  • Combination with systemic antifungal therapy: monitor for rare systemic exposure.
  • Use with skin irritants or harsh cleansers: may exacerbate local reactions.
  • Application on extensive body surface area: observe for increased systemic absorption.

Frequently Asked Questions

Mycoster is a topical antifungal medication indicated for the treatment of dermatophyte infections such as athlete's foot, ringworm and jock itch, as well as candidal skin infections and seborrheic dermatitis. It works on the skin surface to eliminate the fungi responsible for these conditions.

Ciclopirox olamine chelates essential metal ions, inhibiting metal‑dependent enzymes that fungi need for cell membrane transport and metabolic processes. This disruption interferes with fungal respiration and protein synthesis, leading to inhibition of growth and eventual cell death while sparing human cells.

The dosage of Mycoster is determined by the prescribing healthcare professional based on the specific infection, its severity, and the patient’s age. The prescriber will provide instructions on the amount to apply, frequency, and duration of treatment.

Safety data for ciclopirox olamine in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any unknown risks before prescribing. Patients should discuss their pregnancy or breastfeeding status with their clinician before using Mycoster.

To order Mycoster, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycoster contains ciclopirox olamine, a hydroxypyridone class antifungal, which differs from azole or allylamine creams. It offers a broad spectrum against dermatophytes, Candida and Malassezia species and works by metal chelation rather than enzyme inhibition, providing an alternative mechanism for patients who may not respond to other classes.

Mycoster should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight to maintain product stability.

Mycoster is applied topically to the affected skin area. Clean and dry the skin, then spread a thin layer of the product over the lesion as directed by the prescriber, usually once or twice daily, and continue for the prescribed duration even if symptoms improve.

Serious risks, though rare, include severe allergic reactions such as allergic contact dermatitis, urticaria, angioedema, and in extremely uncommon cases, systemic effects like hepatic enzyme changes. Patients should stop use and seek medical attention if they experience swelling, difficulty breathing, or extensive rash.

Mycoster should not be used by individuals with known hypersensitivity to ciclopirox olamine or any of the product’s excipients. It is also contraindicated on broken, inflamed or mucous membranes, and should be avoided in patients who have experienced severe allergic reactions to similar topical antifungals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.